Kynurenines and the respiratory parameters on rat heart mitochondria

Life Sciences

Volumn 72, Issue 10, 2003, Pages 1103-1115

  Baran, Halina ^a   Staniek, K ^a   Kepplinger, B ^a   Stur, J ^a   Draxler, M ^a   Nohl, H ^a  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

ADP; ATP; Cell function; Endogenous uncoupler; Excitatory amino acid receptors; Kynurenic acid; Kynurenines; Mitochondria respiratory parameters

Indexed keywords

3 HYDROXYANTHRANILIC ACID; 3 HYDROXYKYNURENINE; ADENOSINE DIPHOSPHATE; ANTHRANILIC ACID; GLUTAMIC ACID; KYNURENINE; MALIC ACID; OXYGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SUCCINIC ACID; TRYPTOPHAN;

AEROBIC METABOLISM; ARTICLE; CARDIOVASCULAR SYSTEM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; HEART MITOCHONDRION; INCUBATION TIME; MALE; METABOLITE; NONHUMAN; OXYGEN CONSUMPTION; RAT; RESPIRATION CONTROL; RESPIRATORY SYSTEM;

3-HYDROXYANTHRANILIC ACID; ANIMALS; ANTHRANILIC ACIDS; FREE RADICAL SCAVENGERS; KINETICS; KYNURENINE; MALE; MITOCHONDRIA, HEART; MITOCHONDRIAL PROTEINS; NAD; OXYGEN CONSUMPTION; RATS; RATS, SPRAGUE-DAWLEY; SUCCINATES; TRYPTOPHAN;

EID: 0037462277     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)02365-2     Document Type: Article

References (43)

1. Baran H., Amann G., Lubec B., Lubec G. Kynurenic acid and kynurenine aminotransferase in heart. Pediatric Research. 41:1997;404-410.
2. Baran H., Cairns N., Lubec B., Lubec G. Increased kynurenic acid levels and decreased brain kynurenine aminotransferase I in patients with DOWN syndrome. Life Sciences. 58:1996;1891-1899.
3. Baran H., Gramer M., Hönack D., Löscher W. Systemic administration of kainate induces marked increases of endogenous kynurenic acid in various brain regions and plasma of rats. European Journal of Pharmacology. 286:1995;167-175.
4. Baran H., Hainfellner J.A., Kepplinger B., Mazal P.R., Schmid H., Budka H. Kynurenic acid metabolism in the brain of HIV-1 infected patients. Journal of Neural Transmission. 107:2000;1127-1138.
5. Baran H., Jellinger K., Deecke L. Kynurenine metabolism in Alzheimer's disease. Journal of Neural Transmission. 106:1999;165-181.
6. Baran H., Kepplinger B., Herrera-Marschitz M., Lubec G., Stolze K., Nohl H. Increased kynurenic acid in the brain after neonatal asphyxia. Life Sciences. 69:2001;1249-1256.
7. Baran H., Kepplinger B., Staniek K., Stolze K., Gille L., Nohl H. Non-specific aminotransferase inhibitors influence differently the respiratory control parameters of rat heart mitochondria. 6th Symposium of the Austrian Pharmacological Society (APHAR), Vienna, November 24-25. Pharmacology, Abstracts. vol. 61:2000;269-279.
8. Baran H., Nowotny N., Kepplinger B., Scheider H., Url A., Schmidt P., Kalbacher H., Nohl H., Schuh M. Elevated kynurenate levels in serum of piglets infected with encephalomyocarditis virus. 7th Symposium of the Austrian Pharmacological Society (APHAR), Vienna, November 23-24. Pharmacology, Abstracts. vol. 63:2001;240-246.
9. Baran H., Okuno E., Kido R., Schwarcz R. Purification and characterization of kynurenine aminotransferase I from human brain. Journal of Neurochemistry. 62:1994;730-738.
10. Baran H., Schwarcz R. Presence of hydroxyanthranilic acid in rat tissues and evidence for its production from anthranilic acid in the brain. Journal of Neurochemistry. 55:1990;738-744.
11. Baran H., Staniek K., Kepplinger B., Gille L., Stolze K., Nohl H. Kynurenic acid influences the respiratory parameters of rat heart mitochondria. Pharmacology. 62:2001;119-123.
12. Beal M.F., Howell N., Bodis-Wollner I. Mitochondria and Free Radicals in Neurodegenerative diseases. 1996;A John Wiley and Sons Publication.
13. Beal M.F., Matson W.R., Storey E., Milbury P., Ryan E.A., Ogawa T., Bird E.D. Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex. Journal of the Neurological Sciences. 108:1992;80-87.
14. Beal M.F., Matson W.R., Swartz K.J., Gamache P.H., Bird E.D. Kynurenine pathway measurements in Huntingdon's disease striatum. Evidence for reduced formation of kynurenic acid. Journal of Neurochemistry. 55:1990;1327-1339.
15. Benassi C.A., Perissinotto B., Allegri G. The metabolism of tryptophan in patients with bladder cancer and other urological diseases. Clinica Chimica Acta. 8:1963;822-831.
16. Bender D.A., McCreanor G.M. The preferred route of kynurenine metabolism in the rat. Biochemical Biophysical Acta. 717:1982;56-60.
17. 6 and steroid hormone. The American Journal of Clinical Nutrition. 24:1971;243-247.
18. Connick J.H., Carla V., Moroni F., Stone T.W. Increase in kynurenic acid in Huntington's disease motor cortex. Journal of Neurochemistry. 52:1989;958-987.
19. Dykens J.A., Sullivan S.G., Stern A. Oxidative reactivity of the tryptophan metabolites 3-hydroxyanthranilate, cinnabarinate, quinolinate and picolinate. Biochemical Pharmacology. 36:1987;211-217.
20. Eastman C.L., Guilarte T.R. The role of hydrogen peroxide in the in vivo cytotoxicity of 3-hydroxykynurenine. Neurochemical Research. 15:1990;1101-1107.
21. Gramsbergen J.B.P., Schmidt W., Turski W.A., Schwarcz R. Age-related changes in kynurenic acid production in rat brain. Brain Research. 588:1992;1-5.
22. Guidetti P., Walsh J.L., Schwarcz R. A fluorimetric assay for the determination of anthranilic acid in biological materials. Analitical Biochemistry. 220:1994;181-184.
23. Higgins D.S., Greenamyre J.T. Characterization of age related changes in [3H]DHR binding to complex I. 25th Annual Meeting, San Diego, California, November 11-16. Society for Neuroscience, Abstracts. vol. 21(1):1995;574.
24. Higgins D.S. Jr., Greenamyre J.T. [3H]Dihydrorotenone binding to NADH:ubiquinone reductase (complex I) of the electron transport chain: An autoradiographic study. Journal of Neuroscience. 16:1996;3807-3808.
25. Inada J., Okuno E., Kimura M., Kido R. Intracellular localisation and characterisation of 3-hydroxykynureninase in human liver. International Journal of Biochemistry. 16:1984;623-628.
26. Ishii T., Iwahashi H., Sugata R., Kido R. Formation of hydroxanthommatin-derived radical in the oxidation of 3-hydroxykynurenine. Archives of Biochemistry and Biophysics. 294:1992;616-622.
27. Iwahashi H., Ishii T., Sugata R., Kido R. The effects of caffeic acid and its related catechols on hydroxyl radical formation by 3-hydroxyanthranilic acid, ferric chloride, and hydrogen peroxide. Archives of Biochemistry and Biophysics. 276:1990;242-247.
28. Jauch D., Urbanska E.M., Guidetti P., Bird E.D., Vonsattel J.P.G., Whetsell W.O. Jr., Schwarcz R. Dysfunction of brain kynurenic acid metabolism in Huntington's disease: focus on kynurenine aminotransferases. Journal of the Neurological Sciences. 130:1995;39-47.
29. Kawai J., Okuno E., Kido R. Organ distribution of rat kynureninase and changes of its activity during development. Enzyme. 39:1988;181-189.
30. McMaster O.G., Du F., French E.D., Schwarcz R. Focal injection of aminooxyacetic acid produces seizures and lesions in rat hippocampus: Evidence for mediation by NMDA receptors. Experimental Neurology. 113:1991;367-374.
31. McMaster O.G., Baran H., Wu H.-Q., French E.D., Schwarcz R. γ-Acetylenic GABA produces axon-sparing neurodegeneration after focal injection into the rat hippocampus. Experimental Neurology. 124:1993;184-191.
32. Nicholls T., Nitsos I., Walker D.W. Tryptophan metabolism in pregnant sheep: Increased fetal kynurenine production in response to maternal tryptophan loading. American Journal of Obstetrics and Gynecology. 181:1999;1452-1460.
33. Noguchi T., Minatogawa Y., Okuno E., Nakatani M., Morimoto M., Kido R. Purification and characterisation of kynurenine-2-oxoglutarate aminotransferase from the liver, brain and small intestine of rats. The Biochemical Journal. 151:1975;399-406.
34. Nohl H. Oxygen radical release in mitochondria: Influence of age. Johnson J.E., Walford R., Harman D., Miquel J. Free Radicals, Ageing, and Degenerative Diseases. 1986;77-97 Alan R Liss, New York.
35. Okuno E., Nakamura M., Schwarcz R. Two kynurenine aminotransferases in human brain. Brain Research. 542:1991;307-312.
36. Quagliariello E., Papa S., Saccone C., Alifano A. Effect of 3-hydroxyanthranilic acid on the mitochondrial respiratory system. The Biochemical Journal. 91:1964;137-146.
37. Raabe W. Synaptic transmission in ammonia intoxication. Neurochemical Pathology. 6:1987;145-166.
38. Rudziete V., Jurika E., Araja J., Andrejev N. The relationship between kynurenine and arterial blood pressure. Bender D.A., Joseph M.H., Kochen W., Steinhart H. Progress in Tryptophan and Serotonin Research 1986. 1987;127-130 Walter de Gruyter and Co, Berlin-New York.
39. Rudziete V., Skards J.I., Fuchs D., Reibnegger G., Wachter H. Serum kynurenine and neopterin concentrations in patients with cardiomyopathy. Immunology Letters. 32:1992;125-130.
40. Speciale C., Schwarcz R. Uptake of kynurenine into rat brain slices. Journal of Neurochemistry. 54:1990;156-163.
41. 2 detection from intact mitochondria as a measure for one-electron reduction of dioxygen requires a non-invasive assay system. Biochimica Biophysica Acta. 1413:1999;70-80.
42. Stone T.W. Neuropharmacology of quinolinic and kynurenic acids. Pharmacological Reviews. 45:1993;309-379.
43. Whetsell W.O.J., Shapira N.A. Neuroexcitation, excitotoxicity and human neurological disease. Laboratory Investigation. 68(4):1993;372-387.